Publications by authors named "Rika Inose"

Claim this Profile
E
Evaluation of efficacy of aztreonam-nacubactam and cefepime-nacubactam against clinical isolates of .
Wataru Aoki, Yoshifumi Uwamino, Hiroaki Kubota, Yuka Kamoshita, Rika Inose

Antimicrob Agents Chemother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cefiderocol susceptibility of Stenotrophomonas maltophilia species complex and carbapenem-resistant Pseudomonas aeruginosa isolates from blood cultures at a university hospital in Tokyo, Japan.
Wataru Aoki, Yoshifumi Uwamino, Nagi Niida, Hiroaki Kubota, Yuka Kamoshita, Rika Inose

J Glob Antimicrob Resist· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
activity of aztreonam-avibactam combination against blood culture isolates of in Japan before the launch of ceftazidime-avibactam.
Wataru Aoki, Yoshifumi Uwamino, Yuka Kamoshita, Rika Inose, Mika Nagata

Microbiol Spectr· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fully automated identification of Neisseria meningitidis using the BD MAX system in a clinical laboratory setting: A preliminary study.
Rika Inose, Yoshifumi Uwamino, Wataru Aoki, Yuka Kamoshita, Mika Nagata

J Infect Chemother· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal incubation duration of liquid cultures for assessing culture negative conversion in patients with Mycobacterium avium complex and Mycobacterium abscessus pulmonary diseases.
Yoshifumi Uwamino, Naoki Hasegawa, Yuka Kamoshita, Rika Inose, Wataru Aoki

Eur J Clin Microbiol Infect Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimum inhibitory concentrations of azithromycin in clinical isolates of complex in Japan.
Yoshifumi Uwamino, Wataru Aoki, Rika Inose, Yuka Kamoshita, Kei Mikita

Microbiol Spectr· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient automated semi-quantitative urine culture analysis via BD Urine Culture App.
Yoshifumi Uwamino, Mika Nagata, Wataru Aoki, Ai Kato, Miho Daigo, Rika Inose

Diagn Microbiol Infect Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of rapid antigen detection test for nasopharyngeal swab specimens and saliva samples in comparison with RT-PCR and viral culture for SARS-CoV-2 detection.
Yoshifumi Uwamino, Mika Nagata, Wataru Aoki, Terumichi Nakagawa, Rika Inose

J Infect Chemother· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the usability of various rapid antibody tests in the diagnostic application for COVID-19.
Yoshifumi Uwamino, Masatoshi Wakui, Wataru Aoki, Toshinobu Kurafuji, Emmy Yanagita, Rika Inose

Ann Clin Biochem· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seasonal changes in indoor airborne fungal concentration in a hematology ward.
Takehiko Mori, Taku Kikuchi, Jun Kato, Yuya Koda, Masatoshi Sakurai, Rika Inose

J Infect Chemother· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for clinical microbiology in 2014: General view of the pathogens' antibacterial susceptibility.
Katsunori Yanagihara, Tetsuya Matsumoto, Nobuki Aoki, Junko Sato, Tomotaro Wakamura, Rika Inose

J Infect Chemother· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2012: General view of the pathogens' antibacterial susceptibility.
Katsunori Yanagihara, Akira Watanabe, Nobuki Aoki, Tetsuya Matsumoto, Masaki Yoshida, Rika Inose

J Infect Chemother· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Antimicrobial activity of meropenem against main bacterial species isolated from patient blood in 2010].
Yoshio Kobayashi, Yuko Sumitani, Rika Inose, Yasuhiro Katohno

Jpn J Antibiot· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis